Effector and memory T-cell differentiation: implications for vaccine development - PubMed (original) (raw)

Review

doi: 10.1038/nri778.

Affiliations

• PMID: 12001996
• DOI: 10.1038/nri778

Review

Effector and memory T-cell differentiation: implications for vaccine development

Susan M Kaech et al. Nat Rev Immunol. 2002 Apr.

Abstract

Recent work shows that after stimulation with antigen, CD4+ and CD8+ T cells embark on a programme of proliferation that is closely linked with the acquisition of effector functions and leads ultimately to memory-cell formation. Here, we discuss the signals required for commitment to this programme of development and the factors that might influence its progression. Models of the pathways of effector and memory T-cell differentiation are discussed, and we highlight the implications of this new understanding for the optimization of vaccine strategies.

PubMed Disclaimer

Similar articles

• Memory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design.
  Baz A, Jackson DC, Kienzle N, Kelso A. Baz A, et al. Expert Rev Vaccines. 2005 Oct;4(5):711-23. doi: 10.1586/14760584.4.5.711. Expert Rev Vaccines. 2005. PMID: 16221072 Review.
• Memory CD4 T cells emerge from effector T-cell progenitors.
  Harrington LE, Janowski KM, Oliver JR, Zajac AJ, Weaver CT. Harrington LE, et al. Nature. 2008 Mar 20;452(7185):356-60. doi: 10.1038/nature06672. Epub 2008 Mar 5. Nature. 2008. PMID: 18322463
• Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.
  Seder RA, Ahmed R. Seder RA, et al. Nat Immunol. 2003 Sep;4(9):835-42. doi: 10.1038/ni969. Nat Immunol. 2003. PMID: 12942084 Review.
• The role of programming in memory T-cell development.
  Masopust D, Kaech SM, Wherry EJ, Ahmed R. Masopust D, et al. Curr Opin Immunol. 2004 Apr;16(2):217-25. doi: 10.1016/j.coi.2004.02.005. Curr Opin Immunol. 2004. PMID: 15023416 Review.
• Pathways of memory CD8+ T-cell development.
  Bannard O, Kraman M, Fearon D. Bannard O, et al. Eur J Immunol. 2009 Aug;39(8):2083-7. doi: 10.1002/eji.200939555. Eur J Immunol. 2009. PMID: 19637204 Review.

Cited by

• Systems immunology approaches to study T cells in health and disease.
  Yang A, Poholek AC. Yang A, et al. NPJ Syst Biol Appl. 2024 Oct 9;10(1):117. doi: 10.1038/s41540-024-00446-1. NPJ Syst Biol Appl. 2024. PMID: 39384819 Free PMC article. Review.
• Two-dimensional coordination risedronate-manganese nanobelts as adjuvant for cancer radiotherapy and immunotherapy.
  Huang Z, Huang S, Song S, Ding Y, Zhou H, Zhang S, Weng L, Zhang Y, Hu Y, Yuan A, Dai Y, Luo Z, Wang L. Huang Z, et al. Nat Commun. 2024 Oct 8;15(1):8692. doi: 10.1038/s41467-024-53084-w. Nat Commun. 2024. PMID: 39375342 Free PMC article.
• Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature.
  Tsagkli P, Geropeppa M, Papadatou I, Spoulou V. Tsagkli P, et al. Vaccines (Basel). 2024 Sep 14;12(9):1051. doi: 10.3390/vaccines12091051. Vaccines (Basel). 2024. PMID: 39340081 Free PMC article. Review.
• Immunogenicity and Protective Efficacy of a Multi-Antigen Mycobacterium tuberculosis Subunit Vaccine in Mice.
  Nisa A, Pinto R, Britton WJ, Triccas JA, Counoupas C. Nisa A, et al. Vaccines (Basel). 2024 Aug 30;12(9):997. doi: 10.3390/vaccines12090997. Vaccines (Basel). 2024. PMID: 39340027 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program